The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Highly Efficient Asymmetric Synthesis of Sitagliptin
Abstract
A highly efficient synthesis of sitagliptin, a potent and selective DPP-4 inhibitor for the treatment of type 2 diabetes mellitus (T2DM), has been developed. The key dehydrositagliptin intermediate 9 is prepared in three steps in one pot and directly isolated in 82% yield and >99.6 wt % purity. Highly enantioselective hydrogenation of dehydrositagliptin 9, with as low as 0.15 mol % of Rh(I)/(t)Bu JOSIPHOS, affords sitagliptin, which is finally isolated as its phosphate salt with nearly perfect optical and chemical purity. This environmentally friendly, 'green' synthesis significantly reduces the total waste generated per kilogram of sitagliptin produced in comparison with the first-generation route and completely eliminates aqueous waste streams. The efficiency of this cost-effective process, which has been implemented on manufacturing scale, results in up to 65% overall isolated yield.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Ahrén, B., Landin-Olsson, M., Jansson, P.-A., Svensson, M., Holmes, D., & Schweizer, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031907 · Cited by 710
Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
Weber, A. E. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030628v · Cited by 278
Thornberry, N., & Weber, A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780091028 · Cited by 202
First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin
Hansen, K. B., Balsells, J., Dreher, S., Hsiao, Y., Kubryk, M., Palucki, M., Rivera, N., Steinhuebel, D., Armstrong, J. D., Askin, D., et al. (2005) · Organic Process Research & Development · doi:10.1021/op0500786 · Cited by 167
Self-citationDipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On Sitagliptin
Herman, G. A., Stein, P. P., Thornberry, N. A., & Wagner, J. A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100167 · Cited by 166
Inhibitors of Dipeptidyl Peptidase 4
Gwaltney, S. L., & Stafford, J. A. (2005) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(05)40010-x · Cited by 27
Research works printed but not linked: 18
- aInternational Diabetes Federation (IDF), Diabetes Atlas , 3rd Edition, Dec, 2006;http://www.iotf.org/diabetes.asp.
- Andrews M., 2009, U.S. News World Rep., 9
- Gwaltney S. L. II., 2005, Annu. Rep. Med. Chem., 40, 149
- Hsiao Y., 2004, J. Am. Chem. Soc., 126, 9918, 10.1021/ja047901i · doi:10.1021/ja047901i
- Lee N. E., 1994, J. Am. Chem. Soc., 116, 5985, 10.1021/ja00092a066 · doi:10.1021/ja00092a066
- Tararov R., 2000, Tetrahedron Lett., 41, 2351, 10.1016/S0040-4039(00)00197-0 · doi:10.1016/s0040-4039(00)00197-0
- Abdel-Magid A. F., 1999, Curr. Med. Chem., 6, 955, 10.2174/092986730610220401160911 · doi:10.2174/092986730610220401160911
- Drexler H.-J., 2003, Org. Process Res. Dev., 7, 355, 10.1021/op034011z · doi:10.1021/op034011z
- Ma J.-A., 2003, Angew. Chem., Int. Ed., 42, 4290, 10.1002/anie.200301600 · doi:10.1002/anie.200301600
- Sorensen U. S., 2000, J. Org. Chem., 65, 1003, 10.1021/jo991409d · doi:10.1021/jo991409d
- Hamada Y., 1989, J. Am. Chem. Soc., 111, 669, 10.1021/ja00184a041 · doi:10.1021/ja00184a041
- Alker D., 1989, J. Med. Chem., 32, 2381, 10.1021/jm00130a026 · doi:10.1021/jm00130a026
- Maibaum J., 1989, J. Med. Chem., 32, 1571, 10.1021/jm00127a028 · doi:10.1021/jm00127a028
- Shinkai I., 1982, Tetrahedron Lett., 23, 4899, 10.1016/S0040-4039(00)85742-1 · doi:10.1016/s0040-4039(00)85742-1
- Mohri K., 1982, Chem. Pharm. Bull, 30, 3097, 10.1248/cpb.30.3097 · doi:10.1248/cpb.30.3097
- Houghton R. P., 1982, Synthesis, 451, 10.1055/s-1982-29828 · doi:10.1055/s-1982-29828
- Xu F., 2004, J. Am. Chem. Soc., 126, 13002, 10.1021/ja046488b · doi:10.1021/ja046488b
- Clausen A. M., 2006, Org. Process Res. Dev, 10, 723, 10.1021/op050232o · doi:10.1021/op050232o
Cited by
Green Chemistry: Principles and Practice
Anastas, P., & Eghbali, N. (2010) · Chem. Soc. Rev. · doi:10.1039/b918763b · Cited by 5,256
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture
Savile, C. K., Janey, J. M., Mundorff, E. C., Moore, J. C., Tam, S., Jarvis, W. R., Colbeck, J. C., Krebber, A., Fleitz, F. J., Brands, J., et al. (2010) · Science · doi:10.1126/science.1188934 · Cited by 1,756
Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals
Dunetz, J. R., Magano, J., & Weisenburger, G. A. (2016) · Organic Process Research & Development · doi:10.1021/op500305s · Cited by 819
Green Chemistry in the Synthesis of Pharmaceuticals
Kar, S., Sanderson, H., Roy, K., Benfenati, E., & Leszczynski, J. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00631 · Cited by 566
Cabré, A., Verdaguer, X., & Riera, A. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00496 · Cited by 477
Solvents and sustainable chemistry
Welton, T. (2015) · Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rspa.2015.0502 · Cited by 412
Enzymatic reductions for the chemist
Hollmann, F., Arends, I. W. C. E., & Holtmann, D. (2011) · Green Chemistry · doi:10.1039/c1gc15424a · Cited by 377
Metadata
- Authors
- Hansen, K. B., Hsiao, Y., Xu, F., Rivera, N., Clausen, A., Kubryk, M., Krska, S., Rosner, T., Simmons, B., Balsells, J., Ikemoto, N., Sun, Y., Spindler, F., Malan, C., Grabowski, E. J. J., & Armstrong, J. D.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-06-09
- Volume
- 131
- Issue
- 25
- Pages
- 8798-8804
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W1995075366
- Cited by
- 314
- References
- 7
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.